PTC Therapeutics, Inc.

PTC is a global biopharmaceutical company dedicated to the discovery, development and commercialization of clinically differentiated medicines for children and adults living with rare disorders. PTC is advancing a robust and diversified pipeline of transformative medicines as part of its mission to provide access to best-in-class treatments for patients with unmet medical needs. The company’s strategy is to leverage its scientific expertise and global commercial infrastructure to optimize value for patients and other stakeholders.

Current securities

1. Regulation FD Disclosure · Other EventsSep 21, 2026
2. 144 filingSep 9, 2026
3. Entry into a Material Definitive AgreementAug 28, 2026
4. 144/A filingAug 25, 2026
5. 144 filingAug 19, 2026